{"title":"α-赛柏酮通过激活Nrf2信号通路来预防脑缺血再灌注损伤。","authors":"Hailong Yu, Ying Chen, Tianlan Qu, Jing Hang, Xiaoyun Huang, Aipeng Hu, Tianwei Wang, Yahao Gao, Jun Shao, Yuping Li, Yingzhu Chen","doi":"10.1016/j.ejphar.2025.177842","DOIUrl":null,"url":null,"abstract":"<p><p>Neuroinflammation is a significant factor that exacerbates secondary damage following cerebral ischaemia/reperfusion (CI/R) injury. α-Cyperone (CYP), the principal active constituent of the traditional Chinese medicine Cyperus rotundus L., decreases inflammation. Nonetheless, its impact on CI/R injury remains unknown. Here, we examined the potential involvement of CYP in regulating CI/R injury-induced oxidative stress and apoptosis. Middle cerebral artery occlusion was used to establish a model of CI/R injury in male C57BL/6J mice. CYP (5 or 10 mg/kg) was administered by intraperitoneal injection 30 minutes, 24 hours, and 48 hours after model establishment. CYP markedly diminished the lesion volume, enhanced neuronal function and reduced apoptosis and oxidative stress. Moreover, CYP increased Nrf2, HO-1, NQO1, and SOD-1 expression in vivo, protecting neurons against hemin stimulation by facilitating Nrf2 nuclear translocation. ML385 (an Nrf2 inhibitor) fully abolished the protective effects of CYP in vivo following CI/R injury. Our data indicate that CYP mitigates CI/R injury-induced apoptosis and oxidative stress through Nrf2 signalling pathway activation, suggesting the possible therapeutic effect of CYP on CI/R injury.</p>","PeriodicalId":12004,"journal":{"name":"European journal of pharmacology","volume":" ","pages":"177842"},"PeriodicalIF":4.2000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"α-Cyperone safeguards against cerebral ischaemia‒reperfusion injury through the activation of the Nrf2 signalling pathway.\",\"authors\":\"Hailong Yu, Ying Chen, Tianlan Qu, Jing Hang, Xiaoyun Huang, Aipeng Hu, Tianwei Wang, Yahao Gao, Jun Shao, Yuping Li, Yingzhu Chen\",\"doi\":\"10.1016/j.ejphar.2025.177842\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Neuroinflammation is a significant factor that exacerbates secondary damage following cerebral ischaemia/reperfusion (CI/R) injury. α-Cyperone (CYP), the principal active constituent of the traditional Chinese medicine Cyperus rotundus L., decreases inflammation. Nonetheless, its impact on CI/R injury remains unknown. Here, we examined the potential involvement of CYP in regulating CI/R injury-induced oxidative stress and apoptosis. Middle cerebral artery occlusion was used to establish a model of CI/R injury in male C57BL/6J mice. CYP (5 or 10 mg/kg) was administered by intraperitoneal injection 30 minutes, 24 hours, and 48 hours after model establishment. CYP markedly diminished the lesion volume, enhanced neuronal function and reduced apoptosis and oxidative stress. Moreover, CYP increased Nrf2, HO-1, NQO1, and SOD-1 expression in vivo, protecting neurons against hemin stimulation by facilitating Nrf2 nuclear translocation. ML385 (an Nrf2 inhibitor) fully abolished the protective effects of CYP in vivo following CI/R injury. Our data indicate that CYP mitigates CI/R injury-induced apoptosis and oxidative stress through Nrf2 signalling pathway activation, suggesting the possible therapeutic effect of CYP on CI/R injury.</p>\",\"PeriodicalId\":12004,\"journal\":{\"name\":\"European journal of pharmacology\",\"volume\":\" \",\"pages\":\"177842\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-06-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ejphar.2025.177842\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejphar.2025.177842","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
α-Cyperone safeguards against cerebral ischaemia‒reperfusion injury through the activation of the Nrf2 signalling pathway.
Neuroinflammation is a significant factor that exacerbates secondary damage following cerebral ischaemia/reperfusion (CI/R) injury. α-Cyperone (CYP), the principal active constituent of the traditional Chinese medicine Cyperus rotundus L., decreases inflammation. Nonetheless, its impact on CI/R injury remains unknown. Here, we examined the potential involvement of CYP in regulating CI/R injury-induced oxidative stress and apoptosis. Middle cerebral artery occlusion was used to establish a model of CI/R injury in male C57BL/6J mice. CYP (5 or 10 mg/kg) was administered by intraperitoneal injection 30 minutes, 24 hours, and 48 hours after model establishment. CYP markedly diminished the lesion volume, enhanced neuronal function and reduced apoptosis and oxidative stress. Moreover, CYP increased Nrf2, HO-1, NQO1, and SOD-1 expression in vivo, protecting neurons against hemin stimulation by facilitating Nrf2 nuclear translocation. ML385 (an Nrf2 inhibitor) fully abolished the protective effects of CYP in vivo following CI/R injury. Our data indicate that CYP mitigates CI/R injury-induced apoptosis and oxidative stress through Nrf2 signalling pathway activation, suggesting the possible therapeutic effect of CYP on CI/R injury.
期刊介绍:
The European Journal of Pharmacology publishes research papers covering all aspects of experimental pharmacology with focus on the mechanism of action of structurally identified compounds affecting biological systems.
The scope includes:
Behavioural pharmacology
Neuropharmacology and analgesia
Cardiovascular pharmacology
Pulmonary, gastrointestinal and urogenital pharmacology
Endocrine pharmacology
Immunopharmacology and inflammation
Molecular and cellular pharmacology
Regenerative pharmacology
Biologicals and biotherapeutics
Translational pharmacology
Nutriceutical pharmacology.